USD 23.25
(-3.0%)
Year | Eps | Eps Growth |
---|---|---|
2024 | -2.51 USD | 25.3% |
2023 | -3.36 USD | -41.77% |
2022 | -2.37 USD | -243.48% |
2021 | -0.69 USD | 31.0% |
2020 | -1.00 USD | 87.75% |
2019 | -8.16 USD | 30.96% |
2018 | -11.82 USD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q4 | -0.56 USD | 3.45% |
2024 FY | - USD | 25.3% |
2024 Q3 | -0.58 USD | 14.71% |
2024 Q1 | -0.70 USD | 2.78% |
2024 Q2 | -0.68 USD | 2.86% |
2023 Q3 | -0.76 USD | 14.61% |
2023 Q2 | -0.89 USD | 10.1% |
2023 FY | - USD | -41.77% |
2023 Q1 | -0.99 USD | -6.45% |
2023 Q4 | -0.72 USD | 5.26% |
2022 Q2 | -0.48 USD | -100.0% |
2022 Q1 | -0.24 USD | -33.33% |
2022 Q3 | -0.71 USD | -47.92% |
2022 FY | - USD | -243.48% |
2022 Q4 | -0.93 USD | -30.99% |
2021 Q2 | -0.17 USD | -6.25% |
2021 Q1 | -0.16 USD | -60.0% |
2021 Q3 | -0.17 USD | 0.0% |
2021 Q4 | -0.18 USD | -5.88% |
2021 FY | - USD | 31.0% |
2020 FY | - USD | 87.75% |
2020 Q3 | -0.07 USD | 93.81% |
2020 Q4 | -0.10 USD | -46.84% |
2020 Q2 | -1.10 USD | -478.95% |
2020 Q1 | -0.19 USD | -5.56% |
2019 FY | - USD | 30.96% |
2019 Q4 | -0.18 USD | -20.0% |
2019 Q1 | -0.11 USD | 0.0% |
2019 Q2 | -0.09 USD | 16.55% |
2019 Q3 | -0.15 USD | -63.4% |
2018 FY | - USD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
American Well Corporation | -47.50 USD | 94.716% |
Doximity, Inc. | 0.78 USD | 421.795% |
Evolent Health, Inc. | -1.28 USD | -96.094% |
MultiPlan Corporation | -0.14 USD | -1692.857% |
Teladoc Health, Inc. | -1.36 USD | -84.559% |
Veeva Systems Inc. | 3.27 USD | 176.758% |